Kevin Trimm

Chief Product Officer

Kevin is a versatile leader with 20 years of experience at the intersection of data science technology and drug development. As Chief Product Officer, he is responsible for Cytel’s software product strategy, development, and commercialization. Under Kevin’s leadership, Cytel is delivering a comprehensive and transformative software-as-a-service (SaaS) clinical trial design platform. The platform includes over 30 years of proprietary innovation, coupled with open-source technology and artificial intelligence.

Before Cytel, Kevin was Vice President of Product Management at Certara, leading multiple transformational software implementation projects in top-tier pharmaceutical companies. Kevin developed and launched Certara’s first cloud-native SaaS offering. He was also responsible for developing the strategic rationale for key technology acquisitions and contributed to the success of Certara’s initial public offering.

Kevin began his career in contract research, spending a decade at Charles River Laboratories (CRL) where he founded a pharmacokinetic analysis service that became CRL’s first centralized global offering and one of its most profitable. Kevin was also responsible for the development and implementation of several data science software solutions to accelerate drug development.

Kevin is a PhD candidate at McGill University in the Department of Experimental Medicine where he is performing pharmaco-epidemiological research using real-world data. He holds an undergraduate degree from the University of Waterloo.